- 🔴 Insolvency / collective proceedings on file (4)
Think this is wrong? This is an automated estimate — request a human review or correction.
METABOLIC EXPLORER
Public limited company (SA) · RC 423703107 · Active since 1999
Overview
METABOLIC EXPLORER is a public limited company (sa) registered in France, since 1999. The company operates in the scientific research & development sector. With reported revenue of 1.9M EUR in 2022. Its TraceComp score of 73 (B+) indicates moderate risk with some areas to watch. With 26 years of operations, the company has an established track record in its market.
Company Information
- Registration Number
- 423703107
- Legal Form
- Public limited company (SA)
- Registered
- 1999-07-21
Financial Profile
Latest filed accounts: FY 2022 · most recent available in public filings
Multi-year financials & ratios
5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Insolvency & Collective Proceedings
4 insolvency / collective-proceedings notices on file — most recent published 2026-03-26. A material adverse finding for counterparty and credit risk.
Insolvency notice types, titles, publication dates and official Gazette sources.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Research Output
Active research organization. 93 publications · 2,500 citations · h-index 26 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Biochemistry, Genetics and Molecular Biology (50%) · Computer Science (11%) · Agricultural and Biological Sciences (11%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Patent Portfolio
Active patent holder. 46 patents · 44 active · 46 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Revenue down 99% year-on-year
- Net loss reported in FY 2022
- Altman Z-Score in the distress zone — elevated insolvency risk on the model
Data Sources & Freshness
Data sourced from: bulk register.